Chronic Myeloid Leukemia (CML) is a type of cancer of the white blood cells. In CML, blast cells (or immature white blood cells) form and uncontrollably multiply and divide and can impair the body’s ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits for blast-related brain injuries.

Ponatinib hydrochloride is under clinical development by Takeda Pharmaceutical and currently in Phase II for Biliary Tumor.

Dr. Kolibaba is Instructor of Medicine, Division of Hematology and Medical Oncology, and Dr. Druker is Associate Professor of Medicine, Division of Hematology and Medical Oncology, Department of ...

About 9,560 new cases will be diagnosed with CML (5,610 in men and 3,950 in women) About 1,290 people will die of CML (740 men and 550 women) About 15% of all new cases of leukemia are chronic myeloid ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The ...

The 1996 VS HSV GTS-R is one of the most unique Aussie-built cars to come out of the 90s. You either loved it, or hated it, and nothing in between. The car featured bright “Yellah” yellow ...

Information on treatment success rates for AML in adults can be found in Treatment Response Rates for Acute Myeloid Leukemia. Our team is made up of doctors and oncology certified nurses with deep ...

More than 30 states could see subzero temps next week: Report Meteorologists: Upcoming pattern could lead to high energy bills Pacific Northwest may see unusually cold air in late January More ...

Background: The treatment of chronic myeloid leukemia through tyrosine kinase inhibitors (TKIs) has achieved promising efficacy and safety outcomes, however the costs are associated with a substantial ...